4.6 Review

The emerging role of circRNAs and their clinical significance in-human cancers

Journal

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1870, Issue 2, Pages 247-260

Publisher

ELSEVIER
DOI: 10.1016/j.bbcan.2018.06.002

Keywords

circular RNA; microRNA; cancer biomarkers; diagnosis; prognosis; non-coding RNA

Funding

  1. National Science Foundation of China [81370068, 81572376, 81622049]
  2. National Young Topnotch Talent program
  3. Shanghai Municipal Education Commission [175G04]

Ask authors/readers for more resources

Circular RNA (circRNA), a recently discovered subclass of non-coding RNAs (ncRNAs), forms a covalently closed loop with neither a 5' cap structure nor a 3' polyadenylated tail. Generated from precursor mRNA (pre-mRNA) through backsplicing (a type of alternative RNA splicing), the majority of circRNAs are located in the cytoplasm and are widespread among living organisms. They are stable and conserved and exhibit spatiotemporal-specific expression. CircRNAs are known to be involved in the development and progression of multiple diseases, including cancer, by acting as microRNA (miRNA) sponges and by regulating processes such as transcription and translation. The extensively aberrant expression profiles of circRNAs in multiple cancerous tissues make these molecules promising diagnostic biomarkers and therapeutic targets for cancer. Here, we briefly review the characteristics, biogenesis, classification, and functions of circRNAs, with a particular focus on the role of circRNAs in various cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available